E2 ModerateModerate confidencePEM unclearCase-ControlPeer-reviewedMachine draft
Statin Use Is Associated with Bladder Pain Syndrome/Interstitial Cystitis: A Population-Based Case-Control Study.
Huang, C Y, Chung, S D, Kao, L T et al. · Urologia internationalis · 2015 · DOI
Quick Summary
This study found that women who took statin drugs (commonly prescribed to lower cholesterol) were about 1.5 times more likely to develop bladder pain syndrome/interstitial cystitis (BPS/IC) compared to women who didn't take statins. The researchers think statins may damage the protective lining of the bladder, which could contribute to this painful condition.
Why It Matters
This study is relevant to ME/CFS patients because many ME/CFS patients experience comorbid pain syndromes like BPS/IC, and some also use statins for cardiovascular risk reduction. Understanding potential iatrogenic contributions to bladder pain could inform medication decisions in this population and highlight epithelial dysfunction as a shared mechanistic pathway across multiple chronic conditions.
Observed Findings
- Prior statin use was associated with 1.52-fold increased odds of BPS/IC (95% CI: 1.19–1.94) after adjusting for 15 comorbidities.
- Regular statin use showed an adjusted odds ratio of 1.58 (95% CI: 1.20–2.08).
- Irregular statin use showed an adjusted odds ratio of 1.53 (95% CI: 1.02–2.31).
- The association persisted after adjustment for multiple pain-related and systemic conditions including chronic fatigue syndrome and fibromyalgia.
Inferred Conclusions
- Statin use is associated with increased risk of BPS/IC in women.
- Both regular and irregular statin use patterns showed elevated associations, suggesting a possible dose or exposure-response relationship.
- The authors propose epithelial dysfunction of the bladder urothelium as a potential biological mechanism linking statin exposure to BPS/IC.
Remaining Questions
- What is the dose-response relationship and optimal statin exposure duration for increased BPS/IC risk?
- What are the specific mechanisms by which statins induce urothelial epithelial dysfunction?
- Do statin-associated BPS/IC symptoms differ in severity or treatment responsiveness compared to idiopathic BPS/IC?
What This Study Does Not Prove
This study does not prove that statins *cause* BPS/IC—only that an association exists. Because it is observational, reverse causation is possible (people with undiagnosed BPS/IC symptoms might be more likely to seek medical care and receive statins). The study cannot definitively exclude unmeasured confounders or determine mechanism of action.
Tags
Symptom:Pain
Method Flag:Sex-Stratified
Metadata
- DOI
- 10.1159/000431185
- PMID
- 26184102
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →